Intrathecal baclofen treatment in dystonic cerebral palsy: a randomized clinical trial: the IDYS trial

BACKGROUND: Dystonic cerebral palsy is primarily caused by damage to the basal ganglia and central cortex. The daily care of these patients can be difficult due to dystonic movements. Intrathecal baclofen treatment is a potential treatment option for dystonia and has become common practice. Despite...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Main Authors:	Bonouvrié, Laura A, Becher, Jules G, Vles, Johannes SH, Boeschoten, Karin, Soudant, Dan, de Groot, Vincent, van Ouwerkerk, Willem JR, Strijers, Rob LM, Foncke, Elisabeth, Geytenbeek, Joke, van de Ven, Peter M, Teernstra, Onno, Vermeulen, R Jeroen
Format:	Artigo
Sprog:	Inglês
Udgivet:	BioMed Central 2013
Fag:	Study Protocol
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3840690/ https://ncbi.nlm.nih.gov/pubmed/24165282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2431-13-175
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Intrathecal baclofen treatment in dystonic cerebral palsy: a randomized clinical trial: the IDYS trial

Lignende værker